Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) registry: High triglycerides constitute an independent risk factor

Circulation

Volumn 104, Issue 24, 2001, Pages 2892-2897

  Tanne, David ^a,b   Koren Morag, Nira ^d   Graff, Eran ^c   Goldbourt, Uri ^b,d  

^a Department of Neurology   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cerebrovascular disorders; Lipoproteins; Triglycerides

Indexed keywords

BEZAFIBRATE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK;

EID: 0035846653     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc4901.100384     Document Type: Article

References (28)

1. Mortality by cause for eight regions of the world: Global Burden of Disease Study
2. Epidemiology of stroke
3. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association
4. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
5. Reduction of stroke incidence after myocardial infarction with pravastatin: The Cholesterol and Recurrent Events (CARE) study
6. Pravastatin therapy and the risk of stroke
7. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
8. Cholesterol in low and high density lipoproteins and ischemic cerebrovascular disease: The Bezafibrate Infarction Prevention (BIP) Registry
9. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies
10. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
11. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: The Bezafibrate Infarction Prevention (BIP) study
12. Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial)
13. A review of goodness of fit statistics for use in the development of logistic regression models
14. Blood pressure, stroke, and coronary heart disease, I: Prolonged differences in blood pressure. Prospective observational studies corrected for the regression dilution bias
15. Triglyceride concentration and ischemic heart disease: An eight-year follow-up in the Copenhagen Male Study
16. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
17. Banting lecture 1988. Role of insulin resistance in human disease
18. Lipids and stroke: A paradox resolved
19. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: The Copenhagen City Heart Study
20. Lipoproteins, cardiovascular disease, and death. The Framingham study
21. Body height, cardiovascular risk factors, and risk of stroke in middle-aged men and women: A 14-year follow-up of the Finnmark Study
22. Relative importance of various risk factors for asymptomatic carotid atherosclerosis versus coronary heart disease incidence: The Atherosclerosis Risk in Communities Study
23. Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-year-old men
24. Frequency and prognosis of stroke/T1A among 4808 survivors of acute myocardial infarction
25. High-density lipoprotein cholesterol and risk of ischemic stroke mortality: A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study
26. High-density lipoprotein cholesterol and ischemic stroke in the elderly: The Northern Manhattan Stroke Study
27. Reduction in stroke with gemfibrozil in men with coronary heart disease, and low HDL cholesterol. The Veterans Affairs HDL Intervention Trial (VA-HIT)
28. Inaccuracy of the International Classification of Diseases (ICD-9-CM) in identifying the diagnosis of ischemic cerebrovascular disease